Literature DB >> 8971183

Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer.

J L Mauillon1, P Michel, J M Limacher, J B Latouche, P Dechelotte, F Charbonnier, C Martin, V Moreau, J Metayer, B Paillot, T Frebourg.   

Abstract

We analyzed the hMLH1 gene in 17 unrelated families with putative hereditary nonpolyposis colorectal cancer. The complete hMLH1 cDNA was amplified in one step, and after a second amplification, four overlapping segments were directly sequenced. We detected, in five families that did not meet the complete Amsterdam criteria, five alterations, including a double-base change resulting in a missense mutation (Lys-618-Ala), a splicing mutation affecting the intron 4 splice acceptor site, a 2-bp deletion at codon 726, a 7-bp deletion at codon 626, and a deletion of exons 13-16. The latter alteration was shown to result from a 22-kb genomic deletion due to a homologous recombination between Alu repeats located in introns 12 and 16. The detection of five germline hMLH1 mutations in five families that only partially fulfilled the Amsterdam criteria shows that these criteria do not allow the identification of all familial colorectal cancers due to mutations of the mismatch repair genes. The numerous Alu repeats present within the hMLH1 gene and the observation of large genomic deletions suggest that (a) Alu-mediated deletions might frequently be involved in hMLH1 inactivation, and (b) reverse transcription-PCR analysis, which allows the amplification of the entire coding region of the hMLH1 gene in one step, might be the most appropriate method for the detection of hMLH1 alterations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971183

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Characterization of Alu and recombination-associated motifs mediating a large homozygous SPG7 gene rearrangement causing hereditary spastic paraplegia.

Authors:  Eva López; Carlos Casasnovas; Javier Giménez; Antoni Matilla-Dueñas; Ivelisse Sánchez; Víctor Volpini
Journal:  Neurogenetics       Date:  2014-11-16       Impact factor: 2.660

Review 2.  An alternative approach to medical genetics based on modern evolutionary biology. Part 4: HERVs in cancer.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-11       Impact factor: 5.344

3.  Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome.

Authors:  Jihane N Benhammou; Cathy D Vocke; Avni Santani; Laura S Schmidt; Masaya Baba; Kuniaki Seyama; Xiaolin Wu; Susana Korolevich; Katherine L Nathanson; Catherine A Stolle; W Marston Linehan
Journal:  Genes Chromosomes Cancer       Date:  2011-03-15       Impact factor: 5.006

4.  Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome.

Authors:  E Pipiras; A Coquelle; A Bieth; M Debatisse
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

5.  The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors.

Authors:  Fabiola Medeiros; Noralane M Lindor; Fergus J Couch; W Edward Highsmith
Journal:  J Mol Diagn       Date:  2012-03-13       Impact factor: 5.568

6.  Mutator phenotypes conferred by MLH1 overexpression and by heterozygosity for mlh1 mutations.

Authors:  P V Shcherbakova; T A Kunkel
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

7.  Non-truncating hMLH1 variants identified in Slovenian gastric cancer patients are not associated with Lynch Syndrome: a functional analysis report.

Authors:  Matjaz Vogelsang; Radovan Komel
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

8.  Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility?

Authors:  Sara Levene; Gillian Scott; Patricia Price; Jeremy Sanderson; Helen Evans; Claire Taylor; Sylvia Bass; Cathryn Lewis; Shirley Hodgson
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

9.  Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination.

Authors:  Sana Aissi-Ben Moussa; Amel Moussa; Tonio Lovecchio; Nadia Kourda; Taoufik Najjar; Sarra Ben Jilani; Amel El Gaaied; Nicole Porchet; Mohamed Manai; Marie-Pierre Buisine
Journal:  Fam Cancer       Date:  2008-09-16       Impact factor: 2.375

10.  Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.

Authors:  Katarina Zavodna; Tomas Krivulcik; Maria Gerykova Bujalkova; Tomas Slamka; David Martinicky; Denisa Ilencikova; Zdena Bartosova
Journal:  BMC Cancer       Date:  2009-11-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.